+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Adrenoleukodystrophy (ALD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Adrenoleukodystrophy (ALD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sjogren's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sjogren's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis (NCFB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Cystic Fibrosis Bronchiectasis (NCFB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Geographic Atrophy (GA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Geographic Atrophy (GA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Ranibizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Ranibizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Homocystinuria - Epidemiology Insight - 2032 - Product Thumbnail Image

Homocystinuria - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Multiple System Atrophy (MSA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Multiple System Atrophy (MSA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Diabetic foot ulcers - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Diabetic foot ulcers - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Acute Pain - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Acute Pain - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chronic Rhinosinusitis without Nasal Polyps - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Rhinosinusitis without Nasal Polyps - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Vernal Keratoconjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Vernal Keratoconjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Biliary Atresia (BA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Biliary Atresia (BA) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hemophilia B - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemophilia B - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sepsis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sepsis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Heart Failure - Epidemiology forecast- 2032 - Product Thumbnail Image

Heart Failure - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more